| 1 |
27510230 | Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma. | 2017 Feb |
1 |
| 2 |
28542038 | Hypoxia as a target for drug combination therapy of liver cancer. | 2017 Aug |
1 |
| 3 |
26961293 | Trace Elements and Chemotherapy Sensitivity. | 2016 Oct |
2 |
| 4 |
30190939 | Systemic therapy for hepatocellular carcinoma. | 2014 Jan |
1 |
| 5 |
23933933 | Long term recurrence analysis post drug eluting bead (deb) chemoembolization for hepatocellular carcinoma (hcc). | 2013 Sep |
1 |
| 6 |
24266510 | Concepts and Strategies for the Site Specific Delivery of Nanocarrier Based Delivery Systems for Treating Hepatocellular Carcinoma. | 2013 Nov 24 |
1 |
| 7 |
22510407 | Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. | 2012 May 4 |
2 |
| 8 |
20388796 | Molecular mechanism of chemoresistance by astrocyte elevated gene-1. | 2010 Apr 15 |
1 |
| 9 |
17938995 | Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. | 2008 Sep-Oct |
1 |
| 10 |
18486261 | Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. | 2008 Aug |
1 |
| 11 |
19080480 | [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice]. | 2008 Aug 5 |
1 |
| 12 |
16396674 | Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma. | 2006 Jan 5 |
1 |
| 13 |
10838038 | Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model. | 2000 Jul |
1 |